Immunophenotypic changes in peripheral blood of colorectal cancer patients: a potential diagnostic marker for CD4+ monocytes
Khin Aye Thin, Andrew Cross, Phonthep AngsuwatcharakoniD, Apiwat MutiranguraiD, Charoenchai PuttipanyalearsiD, Thomas Pike, Robert Jones, Paul Skaife, Steven W. EdwardsiD
Abstract
Colorectal cancer (CRC) can induce stresses on the immune system that can affect both the numbers and function of these cells and the ability of the tumours to evade immune-surveillance. Changes in immune functions can also occur during ageing and these may affect both the ability to fight infections and to protect against cancers. As the incidence of CRC is age-related, the aim of this work was to identify changes in immune cell subtypes that are specific to CRC and not merely due to age-related changes. The immunophenotypes of peripheral blood lymphocytes and monocytes of CRC patients and age-matched healthy controls (HC) were analysed using flow cytometry and surface marker staining. Compared to HC, a lower L:M ratio was observed starting from the early stages of CRC, while numbers of B lymphocytes were lower and CD4+ monocytes were higher in CRC patients. In most patients with CRC, the numbers of helper T cells were lower, while cytotoxic T cells and NK T cells together with CD4+ NKT and CD8+ NKT cells were higher: classical monocytes were lower while intermediate monocytes were higher throughout the stages of CRC, and HLA-DRlow monocytes were also higher. NKbright cells were higher while NKdim cells were lower in patients with large tumours. Most of the increased numbers of T cells and monocytes in CRC relate to immunosuppressive phenotypes that may aid tumour evasion. The increase in CD4+ monocytes is likely related to increased numbers of intermediate monocytes, and a threshold of 11.6% CD4+ monocytes can be used as diagnostic marker for CRC with a 60% sensitivity and 88% specificity.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 43th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Colorectal cancers with distinct metastatic potential trigger divergent early T cell responses
Marwa Saad, Alexandra Thoms, … Daniel Mucida·The Journal of Experimental MedicinePeer-reviewed·Oct 26, 2026
- Conventional therapy induces tumor immunoediting and modulates the immune contexture in colorectal cancer
Georgios Fotakis, Dietmar Rieder, … Zlatko Trajanoski·bioRxiv·Aug 21, 2024
- The ratio of exhausted to resident infiltrating lymphocytes is prognostic for colorectal cancer patient outcome
M. Foroutan, R. Molania, … N. D. Huntington·bioRxiv·Dec 19, 2020
- A new highly-specific Natural Killer cell-specific gene signature predicting recurrence in colorectal cancer patients.
C. Shembrey, C. Behrenbruch, … F. Hollande·bioRxiv·Apr 29, 2022
- Significant and conflicting correlation of IL-9 with Prevotella and Bacteroides in human colorectal cancer
E. Niccolai, E. Russo, … A. Amedei·bioRxiv·Apr 28, 2020
- Single-cell integration and multi-modal profiling reveals phenotypes and spatial organization of neutrophils in colorectal cancer
Valentin Marteau, Niloofar Nemati, … Zlatko Trajanoski·Cancer CellPeer-reviewed·Jan 1, 2026